Bone scan as a stratification variable in advanced prostate cancer.
The serial technetium 99 (99Tc) bone scans of 76 patients with Stage D-2 prostate cancers were reviewed. Sites of metastases in skeletal areas in decreasing order were vertebrae, ribs, pelvis, long bones, and skull. Patients with one or two involved skeletal areas had a significantly longer progression-free interval and survival time than patients with three or more bony areas of uptake. Bone scans might be used as a stratification variable in future prospective clinical trials of Stage D-2 prostate cancer.
Knudson
G
G
Division of Urology, University of Illinois Hospital, Chicago.
Grinis
G
G
Lopez-Majano
V
V
Sansi
P
P
Targonski
P
P
Rubenstein
M
M
Sharifi
R
R
Guinan
P
P
D000368:Aged; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology; D011877:Radionuclide Imaging; D015996:Survival Rate; D013669:Technetium Tc 99m Medronate
D013669:Technetium Tc 99m Medronate